New Blog - Patient Focused Medicines Development

Recent Stories

The first step is often the most significant

·
Dr Paula Wray, senior public involvement manager at NIHR INVOLVE in the UK has spent nine years in public involvement in applied health research. She attends around 25 patient...
+ Read more

A wonderful reference tool

·
Mary Alice Dwyer PharmD, is a Principal/Consultant at Medical Innovation and Insights who has spent 28 years in the medicines industry, including four of those involved in all aspects...
+ Read more
Sort by
Sort by

More Stories

·

Refreshing to see so many great examples

As a Patient Leader, Consultant and Researcher, Simon Stones attends on average 50 patient engagement events each year. Unsurprisingly, his seven years of experience in the field was invaluable...
·

Patient engagement is a journey

Dr Katherine Deane, BSc PhD, is a Senior Lecturer in Research in the School of Health Sciences at the University of East Anglia,...
·

A valuable resource

Thierry Escudier is Head of Clinical Development at Pierre Fabre Medicament. He has over 30 years in the pharmaceutical industry and is an expert in clinical development. In recent...
·

Unlocking the potential of cohort studies

Research studies following groups of individuals can answer vital medical questions, such as why people suffer from a health problem; or what determines recovery. They are, however, expensive and...
·

A PE trailblazer committed to improving patients’ lives

In a fragmented and fast-evolving patient engagement landscape, the need to align stakeholders, harmonise approaches and perspectives and share best practices is critical as we strive to deliver better...
·

Developing the patient engagement system

Nicholas Brooke, CEO of PFMD, tells Gary Finnegan why solving the patient compensation conundrum will unlock the power of patient engagement Patients, industry and regulators are making patient engagement...
·

Doctors are paid for their expertise, what about patients?

Patients are increasingly seen as playing a valuable role in setting research priorities, designing clinical trials and informing market access decisions. But sometimes they are the only people in...
·

How the National Kidney Foundation is piloting the PEQG

The National Kidney Foundation is the leading organisation in the US dedicated to the awareness, prevention and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions...
X